Merrem I.V. Articles
Generic launches of irinotecan, Primaxin and Merrem
8 February 2012
Cubist's sales jump 47% on Cubicin sales
9 February 2009
Japan stock market week to Dec 8, 2008
15 December 2008
DSP 1st-half profit hit by NHI price revisions
24 November 2008
Carbapenems see increased use for hospital in-patients in Europe
17 November 2008
Cubist income up as Cubicin sales rise 45%
27 October 2008
Cubist to promote AstraZeneca's Merrem in USA
7 July 2008
Dainippon Sumitomo debuts three-year plan
12 March 2007
Patent expiry will "constrain" antibacterial market
15 January 2007
Dainippon Sumitomo net income falls 4.4%
20 November 2006
Dainippon Sumitomo's income leaps 16%
22 May 2006
Japan stock market week to Feb 13, 2006
20 February 2006
Dainippon Sumitomo: strong fiscal half-year
5 December 2005
New indication for AstraZeneca's Merrem
6 June 2005
AstraZeneca submits sNDA for Merrem IV
9 August 2004
MYSTIC releases five-year results
29 April 2002
Tokyo pharma stocks - week to November 5
7 November 2001
AstraZeneca sales rise 8%, Nexium doing well
26 July 2001
AstraZeneca hit by slip in Losec sales
26 April 2001
FDA approves AstraZeneca sterile unit
25 May 2000
AstaZeneca gains orphan drug status for Merrem
18 May 2000
Zeneca consolidates Thai business
9 March 1999
Sumitomo selling antibiotic in China
4 January 1999
Will New Wave Of Antibiotics Fight Resistance?
23 October 1997
National And Multinational News In Brief From Japan
23 October 1997
Zeneca Sees Strong Growth Against The Odds
8 August 1997
Upbeat UK Companies At Goldman Sachs Conference
17 June 1997
Antibiotic Effects Differ In Sepsis
23 September 1996
Strong Fundamentals On Show At Zeneca
19 August 1996
EUROPE STOCK COMMENT
1 July 1996
Zeneca's Merrem Gets FDA Approval
1 July 1996
Merck's New Drugs For Arthritis And Infections
27 May 1996
Zeneca Posts Strong Growth In Germany
8 April 1996
Independent Position To Be Maintained At Zeneca
18 March 1996
Zeneca Reveals Typically Strong Pipeline
18 December 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
Sumitomo Pharma: Meropen
2 October 1995
Sumitomo: Meropen approval in Japan
3 July 1995
Good Performance Forecast For Euro Drugmakers
26 June 1995
European Stock Comment
27 March 1995
Meropenem Launch In UK
13 March 1995
New Chemical Entities Round-Up For 1994
6 February 1995
Zeneca's Merrem Set For European Roll-Out
28 November 1994
New Quinolone: Daiichi's DU-6859a
7 November 1994
New Production Unit For Zeneca In Italy
10 October 1994
Zeneca Gets First Full Approval For Merrem
5 September 1994
Meropenem Effective For Bacterial Meningitis
22 August 1994
ZENECA LAUNCHES AMPHOCIL IN UK
16 May 1994
ZENECA'S PIPELINE ON TARGET AS TENORMIN SLIPS
14 March 1994
ZENECA SUBMITS TWO MERREM NDAs in USa
8 November 1993
ZENECA IN EUROPEAN DEAL WITH LIPOSOME
23 August 1993
ENCOURAGING RESULTS FOR ZENECA'S MERREM
5 July 1993
SMITHKLINE BEECHAM LICENSES THREE DRUGS
5 April 1993
ZENECA ANTIBIOTIC IN MENINGITIS STUDY
5 April 1993
EUROPE STOCK COMMENT
18 January 1993
ZENECA FILES 1ST NDA FOR MERREM
4 January 1993
ZENECA'S PROMISING R&D PIPELINE PRESENTED
14 December 1992
SUMITOMO FILES FOUR NDA'S
7 December 1992
ANALYST R&D UPDATE FROM ICI
6 January 1992
Showing 1-68 of 68 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
